Page last updated: 2024-09-05

sb 203580 and furafylline

sb 203580 has been researched along with furafylline in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(furafylline)
Trials
(furafylline)
Recent Studies (post-2010) (furafylline)
3,48941,137121242

Protein Interaction Comparison

ProteinTaxonomysb 203580 (IC50)furafylline (IC50)
Cytochrome P450 1A2Homo sapiens (human)2.5292
Cytochrome P450 2C19Homo sapiens (human)0.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonios, D; Gautier, JC; Lacour, S; Pallardy, M1

Other Studies

1 other study(ies) available for sb 203580 and furafylline

ArticleYear
Acetaminophen and lipopolysaccharide act in synergy for the production of pro-inflammatory cytokines in murine RAW264.7 macrophages.
    Journal of immunotoxicology, 2009, Volume: 6, Issue:2

    Topics: Acetaminophen; Animals; Anthracenes; Cell Line; Cytochrome P-450 CYP1A2 Inhibitors; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; Indomethacin; Interleukin-1beta; Lipopolysaccharides; Macrophages; MAP Kinase Kinase 1; MAP Kinase Kinase 4; Mice; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines; Signal Transduction; Theophylline; Tumor Necrosis Factor-alpha

2009